Literature DB >> 21935653

Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation.

Vicki Modell1, Bonnie Gee, David B Lewis, Jordan S Orange, Chaim M Roifman, John M Routes, Ricardo U Sorensen, Luigi D Notarangelo, Fred Modell.   

Abstract

A large population of patients with recurring infections are undiagnosed or under diagnosed and Primary Immunodeficiency (PI) is more common than had been previously estimated. The results strongly indicate the measurable impact of Physician Education and Public Awareness in identifying patients with an underlying PI. The Jeffrey Modell Centers Network (JMCN) provides the infrastructure for referral, diagnosis and appropriate treatment. All disease classifications and identified defects increased significantly over the study period. Quality of Life for referred and diagnosed patients dramatically improved compared to undiagnosed patients. There is a substantial cost savings for diagnosed patients compared to undiagnosed, even if regular IgG is required. The SPIRIT(®) Software successfully identified patients with PI in a large database and at three pilot sites. The Software was successfully tested for specificity and sensitivity.

Entities:  

Mesh:

Year:  2011        PMID: 21935653     DOI: 10.1007/s12026-011-8241-y

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  18 in total

Review 1.  Molecular defects in T- and B-cell primary immunodeficiency diseases.

Authors:  Charlotte Cunningham-Rundles; Prashant P Ponda
Journal:  Nat Rev Immunol       Date:  2005-11       Impact factor: 53.106

2.  Sources of health insurance and characteristics of the uninsured: analysis of the March 2007 Current Population Survey.

Authors:  Paul Fronstin
Journal:  EBRI Issue Brief       Date:  2007-10

3.  Immunology today and new discoveries: building upon legacies of Dr. Robert A. Good.

Authors:  Fred Modell
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years.

Authors:  Mary Lucas; Martin Lee; Jenny Lortan; Eduardo Lopez-Granados; Siraj Misbah; Helen Chapel
Journal:  J Allergy Clin Immunol       Date:  2010-05-14       Impact factor: 10.793

Review 5.  Key aspects for successful immunoglobulin therapy of primary immunodeficiencies.

Authors:  C Cunningham-Rundles
Journal:  Clin Exp Immunol       Date:  2011-06       Impact factor: 4.330

6.  Primary immunodeficiencies: 2009 update.

Authors:  Luigi D Notarangelo; Alain Fischer; Raif S Geha; Jean-Laurent Casanova; Helen Chapel; Mary Ellen Conley; Charlotte Cunningham-Rundles; Amos Etzioni; Lennart Hammartröm; Shigeaki Nonoyama; Hans D Ochs; Jennifer Puck; Chaim Roifman; Reinhard Seger; Josiah Wedgwood
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

7.  From genotype to phenotype. Further studies measuring the impact of a Physician Education and Public Awareness Campaign on early diagnosis and management of primary immunodeficiencies.

Authors:  Fred Modell; Diana Puente; Vicki Modell
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 8.  Primary immunodeficiencies.

Authors:  Megan A Cooper; Thomas L Pommering; Katalin Korányi
Journal:  Am Fam Physician       Date:  2003-11-15       Impact factor: 3.292

Review 9.  Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review.

Authors:  P Wood; S Stanworth; J Burton; A Jones; D G Peckham; T Green; C Hyde; H Chapel
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

Review 10.  Consensus on diagnosis and management of primary antibody deficiencies. Consensus Panel for the Diagnosis and Management of Primary Antibody Deficiencies.

Authors:  H M Chapel
Journal:  BMJ       Date:  1994-02-26
View more
  51 in total

1.  Health-related quality of life (HRQL) in immunodeficient adults with selective IgA deficiency compared with age- and gender-matched controls and identification of risk factors for poor HRQL.

Authors:  G H Jörgensen; A Gardulf; M I Sigurdsson; S Arnlaugsson; L Hammarström; B R Ludviksson
Journal:  Qual Life Res       Date:  2014-03       Impact factor: 4.147

2.  Primary immunodeficiency diseases: a 30-year patient registry from the referral center for primary immunodeficiencies in Greece.

Authors:  Athanasios Michos; Maria Raptaki; Sofia Tantou; Marianna Tzanoudaki; Kleopatra Spanou; Manolis Liatsis; Nikki Constantinidou; Evangelia Paschali; Ioanna Varela; Olga Moraloglou; Chryssa Bakoula; Maria Kanariou
Journal:  J Clin Immunol       Date:  2014-07-01       Impact factor: 8.317

3.  Hereditary Homozygous C3 Deficiency.

Authors:  Jigna N Bathia; Priyankar Pal; Mandira Roy; Souvik Guha
Journal:  Indian J Pediatr       Date:  2017-04-24       Impact factor: 1.967

Review 4.  The spread of the J Project.

Authors:  Zsuzsa Horváth; Nima Rezaei; Ismail Reisli; Irina Tuzankina; Nurzhan Otarbayev; Panteley Popandopulo; László Maródi
Journal:  J Clin Immunol       Date:  2013-05-19       Impact factor: 8.317

5.  An analysis and decision tool to measure cost benefit of newborn screening for severe combined immunodeficiency (SCID) and related T-cell lymphopenia.

Authors:  Vicki Modell; Megan Knaus; Fred Modell
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

6.  Primary Immunodeficiency Diseases: Need for Awareness and Advocacy in India.

Authors:  Surjit Singh; Sudhir Gupta
Journal:  Indian J Pediatr       Date:  2016-02-29       Impact factor: 1.967

7.  Modeling primary immunodeficiency disease epidemiology and its treatment to estimate latent therapeutic demand for immunoglobulin.

Authors:  Jeffrey S Stonebraker; Albert Farrugia; Benjamin Gathmann; Jordan S Orange
Journal:  J Clin Immunol       Date:  2013-12-12       Impact factor: 8.317

8.  Primary immunodeficiency diseases in children: 15 year experience in a tertiary care medical center in Qatar.

Authors:  Mohammad S Ehlayel; Abdulbari Bener; Mohammad Abu Laban
Journal:  J Clin Immunol       Date:  2012-10-03       Impact factor: 8.317

9.  Primary immunodeficiency diseases worldwide: more common than generally thought.

Authors:  Ahmed Aziz Bousfiha; Leïla Jeddane; Fatima Ailal; Ibtihal Benhsaien; Nizar Mahlaoui; Jean-Laurent Casanova; Laurent Abel
Journal:  J Clin Immunol       Date:  2012-07-31       Impact factor: 8.317

10.  Switching Patients to Home-Based Subcutaneous Immunoglobulin: an Economic Evaluation of an Interprofessional Drug Therapy Management Program.

Authors:  Clemence Perraudin; Aline Bourdin; Francois Spertini; Jérôme Berger; Olivier Bugnon
Journal:  J Clin Immunol       Date:  2016-05-02       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.